30-Month Stay Proposal Would Delay Generics, Should Be Withdrawn, GPhA Says
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed rule on 30-month stays would discourage timely suits by brand-name firms and should not be implemented, according to the Generic Pharmaceutical Association